<DOC>
	<DOCNO>NCT01486316</DOCNO>
	<brief_summary>The purpose study characterize feasibility impact diagnostic tool may help clinician identify patient high risk visit hospital heart failure event . The study use non-experimental device insert skin chest , continuously monitor heart rhythm combination experimental web-based heart failure risk status . Patients atrial fibrillation heart failure evaluate collect data potential risk status help improve patient outcome .</brief_summary>
	<brief_title>Diagnostic Device Risk Management Atrial Fibrillation Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patient 18 year age old Patient ( patient 's legally authorize representative ) willing able provide write informed consent Patient willing able comply protocol , include followup visit Documented paroxysmal persistent atrial fibrillation strong suspicion atrial fibrillation ( i.e , palpitation ) Patient indicate Reveal XT insertable cardiac monitor commerciallyavailable substantially equivalent Medtronic insertable cardiac monitor Recent HF event within prior 120 day ( HF event define meet one follow two criterion : 1 . Admission primary diagnosis HF 2 . Intravenous HF therapy ( e.g . IV diuretics/vasodilators ) ultrafiltration one follow setting : admission secondary/tertiary diagnosis HF , emergency department , ambulance , observation unit , urgent care , HF/cardiology clinic , patient 's home Willing able transmit data via CareLink Patient pregnant Patient participate another study may interfere IDENTIFYHF protocol require procedure Endstage ( Stage D New York Heart Association class IV ) heart failure Asymptomatic ( Stage B New York Heart Association class I ) heart failure Severe aortic stenosis insufficiency Existing insertable cardiac monitor implant 1 year Existing implantable pulse generator , implantable cardioverter defibrillator , cardiac resynchronization therapy device Severe renal impairment ( estimate glomerular filtration rate &lt; 25mL/min ) Myocardial infarction within prior 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>